Christopher Moreau, CEO and Director of Algernon Pharmaceuticals Inc. (CSE: AGN | FRANKFURT: AGW0 | OTCQB: AGNPF) highlights how DMT offers a new way of thinking about stroke treatments.
Algernon Pharmaceuticals is a C…
Home
Feed
Search
Library
Download